Journal of Drug Discovery and Research

DOI PREFIX 10.67238
FREQUENCY Annual (One issue per year)
×

Contact Emails

drugresearchjournal@globalmeetx.net
support@globalmeetx.com
editorial@globalmeetx.com
finance@globalmeetx.com

Article Processing Timeline

2–6 Days
Typical initial quality and plagiarism check
21–30 Days
Typical peer-review period
45–60 Days
Typical overall processing time

Processing times are indicative and may vary depending on manuscript type, editorial assessment, reviewer availability, revision requirements, ethical or technical checks, author response times, and production requirements.

Editorial Board

Amgad M Rabie (PhD)

Senior Pharmacist
Department of Drug Discovery and Clinical Research, Dikernis General Hospital
Egypt
[Institutional Profile Link]

Pedro Fonte (PhD)

Assistant Professor
Faculty of Sciences and Technology, University of Algarve
Portugal
[Institutional Profile Link]

Duo Liu (Ph.D)

Professor
Department of Pharmacy, Harbin Medical University Cancer Hospital
China
[Institutional Profile Link]

Chan Siok Yee (PhD)

Associate Professor
Department of Pharmaceutical Science, Universiti Sains Malaysia
Malaysia
[Institutional Profile Link]

Narsimha Mamidi (PhD)

Staff Scientist
Department of Pharmacy, University of Wisconsin
United States
[Institutional Profile Link]

Shazia Usmani (PhD)

Professor
Department of Pharmacy, Integral University
India
[Institutional Profile Link]

Fawzy A Saad (Ph.D.)

Chief Executive Officer
Department of Drug Discovery, Saad Pharmaceuticals
Estonia

Yasameen Hmeed Jasim AL-Daraji (PhD)

Lecturer
Department of Applied Chemistry, University of Samarra
Iraq
[Institutional Profile Link]

About the Journal

Overview

The Journal of Drug Discovery and Research is a peer-reviewed, open-access journal dedicated to the publication of scholarly research in drug discovery, pharmaceutical sciences, and therapeutic development. The journal provides a platform for researchers, scientists, pharmacists, clinicians, and other professionals to communicate research findings concerning the discovery, design, development, evaluation, and application of medicines and therapeutic technologies.

The journal welcomes research across a broad range of areas, including medicinal chemistry, pharmacology, toxicology, molecular modeling, computational drug discovery, high-throughput screening, pharmacokinetics, pharmacodynamics, pharmaceutical analysis, drug delivery systems, biopharmaceuticals, natural products, and translational pharmaceutical research. The journal also welcomes interdisciplinary studies involving emerging technologies and approaches relevant to drug discovery and therapeutic development.

The Journal of Drug Discovery and Research publishes original research articles, review articles, case studies, short communications, technical perspectives, and other scholarly contributions appropriate to the journal's scope. Manuscripts may address basic, applied, translational, computational, preclinical, or clinical aspects of pharmaceutical and therapeutic research, subject to the journal's editorial policies and scope.

The journal supports the responsible exchange of scientific information among researchers, scientists, healthcare professionals, and other stakeholders involved in pharmaceutical and therapeutic research. Manuscripts are considered in accordance with the journal's author guidelines, editorial policies, ethical requirements, and peer-review procedures.

The journal is committed to responsible scholarly communication, research integrity, transparent editorial practices, accurate publication metadata, and the responsible dissemination of research in drug discovery and pharmaceutical science.

Aim and Scope

The Journal of Drug Discovery and Research publishes original research articles, reviews, short communications, case studies, and technical perspectives that explore all facets of drug discovery, pharmaceutical innovation, and therapeutic development. We welcome submissions in a variety of thematic areas, including (but not limited to):

Medicinal Chemistry & Drug Design

  • Rational drug design, structure–activity relationships (SAR), and lead optimization
  • Synthesis, characterization, and evaluation of novel bioactive compounds
  • Natural products, synthetic molecules, and peptide-based therapeutics
  • Chemical biology, target identification, and mechanistic studies

Computational & AI-Driven Drug Discovery

  • Molecular docking, virtual screening, pharmacophore modeling, and QSAR analyses
  • Molecular dynamics simulations and in silico ADMET predictions
  • AI/ML-enabled hit identification, de novo drug design, and systems-level modeling

Pharmacology, Toxicology & ADME Studies

  • In vitro and in vivo pharmacological evaluations of drug candidates
  • Toxicity studies, safety profiling, and dose-response assessments
  • Pharmacokinetics (PK), pharmacodynamics (PD), and drug–drug interaction analyses
  • Biomarker discovery, target validation, and mechanistic pharmacology

Drug Delivery Systems & Nanopharmaceuticals

  • Nanocarriers, liposomes, polymeric nanoparticles, and targeted delivery platforms
  • Controlled-release systems, transdermal, mucosal, and inhalation delivery technologies
  • Biocompatibility, stability, and performance of advanced delivery systems

Biopharmaceuticals, Biotechnology & Advanced Therapeutics

  • Monoclonal antibodies, recombinant proteins, and biosimilars
  • Gene therapy, RNA-based therapeutics, and cellular therapies
  • Immunotherapy, vaccine development, and engineered biologics

Pharmaceutical Analysis & Quality Assurance

  • Analytical method development, validation, and impurity profiling
  • Chromatographic, spectroscopic, and mass spectrometric characterization
  • Stability studies, quality control, and regulatory compliance
  • Analytical approaches for complex and biological formulations

Clinical Research & Translational Drug Development

  • Preclinical-to-clinical translation strategies
  • Early-phase clinical trials, dose optimization, and therapeutic index assessment
  • Precision medicine, personalized therapies, and biomarker-driven clinical studies
  • Pharmacovigilance, real-world evidence, and post-marketing evaluations

Natural Products, Traditional Medicines & Bioactive Compounds

  • Isolation, characterization, and pharmacological assessment of natural products
  • Ethnopharmacology and traditional medicinal systems
  • Standardization, quality, and mechanistic insights into natural therapeutics

Emerging, Interdisciplinary & Applied Pharmaceutical Sciences

  • Drug repurposing, polypharmacology, and multi-target therapeutics
  • Industrial drug development, formulation technologies, and scale-up innovations
  • Regulatory science, policy, and ethics in drug research and development
  • Intellectual property, commercialization, and technology transfer

Editorial and Peer-Review Policy

Journal of Drug Discovery and Research follows the editorial and peer-review procedures described in the journal's policies and author guidelines. Manuscripts are assessed for relevance to the journal's scope, originality, scientific merit, methodological considerations, ethical compliance, and suitability for publication.

Key features include:

  • Manuscripts are evaluated by appropriate reviewers and/or editors with relevant subject expertise, according to the journal's stated peer-review model.
  • The applicable peer-review model and reviewer confidentiality arrangements are described in the journal's policies.
  • Editorial assessment considers scientific relevance, originality, methodological quality, ethical compliance, and alignment with the journal's scope.
  • Manuscripts undergo appropriate originality, plagiarism, and research-integrity checks before or during the editorial process.
  • Final publication decisions are made by the responsible editor in accordance with the journal's editorial policies and the outcome of the applicable review process.

Publication Frequency & Format

The journal's publication frequency is Annual (One issue per year). Accepted articles are made available online in HTML and PDF formats following completion of the applicable editorial and production processes, supporting accessible and timely dissemination of published research.

Open Access Policy

Journal of Drug Discovery and Research operates under an open-access publishing model. Published content is freely accessible to readers without subscription or paywall restrictions, subject to the applicable journal policies and licensing terms.

Copyright, licensing, and reuse rights are governed by the terms specified for the journal and individual published content.

Indexing & Archiving

The Journal of Drug Discovery and Research seeks to make its published research discoverable through appropriate scholarly indexing, abstracting, and discovery services. Inclusion in any external indexing or abstracting service is subject to the eligibility requirements, evaluation procedures, and acceptance decisions of the respective service.

The journal is committed to maintaining accurate article metadata, persistent identifiers, accessible article landing pages, and the continued availability of published scholarly content.

Information about indexing, abstracting, discovery, and preservation services is provided on a service-specific basis and is updated when the relevant status has been established and verified.

Manuscript Submission

Authors are encouraged to submit their manuscripts through the journal's Online Submission System (Submit Manuscript).

Manuscripts must adhere to the journal's author guidelines regarding structure, formatting, referencing style, ethical approvals, and necessary disclosures (such as conflicts of interest and funding).

Publication Ethics & Integrity

Journal of Drug Discovery and Research follows internationally recognized standards for publication ethics and research integrity, which include (but are not limited to):

  • Make sure you have ethical approval.
  • Ensure that informed consent is obtained where required and protect the confidentiality and privacy of participants and research subjects.
  • Declare any conflicts of interest.
  • Be transparent about data availability.
  • Clarify authorship criteria and the roles of contributors.
  • Conduct anti-plagiarism checks.
  • Have a clear policy for retraction and correction.

Journal Benefits

  • International Peer-Reviewed Scholarly Journal
  • Open Access Publishing for Broad Dissemination of Scholarly Research
  • Crossref DOI Registration for Published Articles, Where Applicable
  • Established Single-Blind Peer-Review Process
  • Qualified Editorial and Reviewer Network
  • Transparent and Responsible Scholarly Publishing Practices
  • Commitment to Research Integrity, Transparency, and Accurate Scholarly Communication
  • Online Publication Following Editorial Acceptance and Production Completion
  • Persistent Article Identification and Ongoing Availability of Published Content
  • Broad Multidisciplinary and Interdisciplinary Research Coverage
  • Author Support Throughout the Editorial and Publication Process
  • Scholarly Discovery and Indexing Status Reported on a Service-Specific Basis
  • Publication Ethics and Editorial Practices Consistent with Applicable Scholarly Standards
  • Commitment to Rigorous and Responsible Scholarly Research
  • Dedicated Special Issues and Thematic Research Collections, Where Applicable
  • Support for Open Science, Research Reproducibility, and Scholarly Collaboration, Where Applicable

JOURNAL PARTICULARS

Title Journal of Drug Discovery and Research
Frequency Annual (One issue per year)
ISSN 3107-720X (Online)
Publisher Name GlobalMeetX Publishing
Legal / Parent Organization CONVE INTERNATIONAL PVT LTD
Starting Year 2025
Subject Medical Sciences
Language English
Publication Format Online
Email support@globalmeetx.com
Mobile No (+91) 9177731784
Publisher Address Radha Residency, 4th Floor, Sai Priya Gardens, Madhurawada, 530041, Andhra Pradesh, India.

Scholarly Discovery & Publishing Standards

Supporting discoverability, accessibility, research integrity, and responsible stewardship of published scholarly content through appropriate publishing practices and scholarly infrastructure.

Scholarly Discovery & Publishing Standards

Supporting the discoverability, accessibility, integrity, and responsible stewardship of published scholarly content through appropriate publishing practices and scholarly infrastructure.

Google Scholar Google Scholar
Semantic Scholar Semantic Scholar
Scilit Scilit
OpenAlex OpenAlex

Discovery and indexing availability may vary by service and is subject to the individual service's policies and evaluation criteria.

Journal Identifiers

ISSN
ISSN

A unique international identifier used to identify the journal as a continuing serial publication.

Crossref DOI
Crossref DOI

Persistent identifiers are assigned to published scholarly content where applicable and registered with Crossref to support persistent identification and linking.

ORCID
ORCID

ORCID identifiers help distinguish researchers and support accurate attribution of authorship and scholarly contributions. ORCID information may be collected and displayed where provided by authors and supported by the journal's publishing workflow.

Our Publishing Standards

  • Publication Ethics
  • ICMJE Recommendations
  • Creative Commons (CC BY)
  • Ethical Publishing
  • Peer Review Integrity
  • Data & Privacy Protection

Submit Manuscript